✦ LIBER ✦

Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients

✍ Scribed by Massimo Martino; Giuseppe Console; Vincenzo Callea; Caterina Stelitano; Elisabetta Massara; Giuseppe Irrera; Giuseppe Messina; Fortunato Morabito; Pasquale Iacopino

Book ID: 114794108
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 495 KB
Volume: 78
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2006.00774.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential Bortezomib, Dexamethasone, an

Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma

✍ Firoozeh Sahebi; Paul H. Frankel; Len Farol; Amrita Y. Krishnan; Ji-lian Cai; Ge 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Thalidomide plus dexamethasone as a main

Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma

✍ Angelo Maiolino; Vania T.M. Hungria; Marcia Garnica; Gislaine Oliveira-Duarte; L 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

Thalidomide-Dexamethasone as Induction T

Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency

✍ Patrizia Tosi; Elena Zamagni; Paola Tacchetti; Michela Ceccolini; Giulia Perrone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Thalidomide, dexamethasone and lovastati

Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma

✍ Marek Hus; Norbert Grzasko; Marta Szostek; Andrzej Pluta; Grzegorz Helbig; Dariu 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Bortezomib with thalidomide plus dexamet

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB

High complete remission rate and durable

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

✍ Basak Oyan; Yener Koc; Evren Ozdemir; Ayse Kars; Alev Turker; Gulten Tekuzman; E 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB